FGS1 Email Announcements

Appendix E CSELS survey emails with logocleared_survey 1final4OMB 5-26-15.docx

Improving the Impact of Laboratory Practice Guidelines: A New Paradigm for Metrics- Clinical and Laboratory Standards Institute

FGS1 Email Announcements

OMB: 0920-1088

Document [docx]
Download: docx | pdf

Appendix E



Pre survey announcement, first survey:



           


Dear Sir/Madam:


The Clinical and Laboratory Standards Institute (CLSI), in collaboration with the Centers for Disease Control and Prevention (CDC), is conducting a study to improve the usefulness of laboratory practice guidelines (LPGs) that address fingerstick glucose testing procedures. As a facility that may potentially perform point-of-care fingerstick glucose testing, you have been selected to receive this survey. This survey should be completed by the individual at your site who is responsible for developing your fingerstick glucose testing procedures.


A link to the survey will be distributed by e-mail within the next 4 –6 weeks. Participation in this study is voluntary and responses will be anonymous. CLSI will collect and analyze the data and share with CDC. By responding to this survey, you can provide information that will help CLSI improve the usefulness of its laboratory practice guidelines that address fingerstick glucose testing procedures; with an overall goal to improve the quality of care provided to all patients in any health care setting.


Upon completing the survey, all respondents will be provided with a link to select a single electronic copy of a CLSI guideline related to fingerstick glucose testing (a $130 value).


Thank you for your help with this important study.


R egards,

 

David E. Sterry, MT (ASCP)

Director, Standards

Secretary, ISO/TC 212

Clinical and Laboratory Standards Institute

950 West Valley Road, Suite 2500

Shape1

The mark ‘CDC’ is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise. CDC collaboration in this study is not an endorsement by the Department of Health and Human Services (HHS) or CDC of any particular product, service, or enterprise.

Wayne, PA  19087 USA www.clsi.org

Direct Line: 484.588.5942

Fax: 610.688.0700

Email: [email protected]











First Survey announcement:


           


Dear Sir/Madam:


Thank you for taking the time to complete this survey developed by the Clinical and Laboratory Standards Institute (CLSI) in collaboration with the Centers for Disease Control and Prevention (CDC). Your feedback is important for guiding CLSI and CDC in their efforts to improve the usefulness of laboratory practice guidelines; with an overall goal to improve the quality of care provided to all patients in any health care setting.


This survey should be completed by the individual at your site who is responsible for developing your fingerstick glucose testing procedures. The survey should take approximately 15 minutes to complete. Participation in this study is voluntary and responses will be anonymous. CLSI will collect and analyze the data and share with CDC.


Please use the following link to access the survey: SURVEY_URL. The survey will be available until month/date/year.


Please contact Mr. David Sterry ([email protected]) if you have any questions about the survey or who should complete the survey. Upon completing the survey, all respondents will be provided a link that will permit the download of a single electronic copy of a CLSI guideline related to fingerstick glucose testing (a $130 value). CDC collaboration in this study is not an endorsement by the Department of Health and Human Services (HHS) or CDC of any particular product, service, or enterprise.


Thank you for your help with this important study.


Regards,

 

David E. Sterry, MT (ASCP)

Director, Standards

Secretary, ISO/TC 212

Clinical and Laboratory Standards Institute

950 West Valley Road, Suite 2500

Shape2

The mark ‘CDC’ is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise.

Wayne, PA  19087 USA www.clsi.org

Direct Line: 484.588.5942

Fax: 610.688.0700

Email: [email protected]











Reminder email, first survey:



           



Dear Sir/Madam:


If you have not yet completed the Clinical and Laboratory Standards Institute (CLSI)/Centers for Disease Control and Prevention (CDC) survey, this e-mail serves as a reminder for you to complete the survey at the following link: SURVEY_URL. The survey will be available until month/date/year.


Thank you for taking the time to complete this survey by CLSI in collaboration with CDC. Your feedback is important for guiding CLSI and CDC in their efforts to improve the usefulness of laboratory practice guidelines; with an overall goal to improve the quality of care provided to all patients in any health care setting. This survey should be completed by the individual at your site who is responsible for developing your fingerstick glucose testing procedures. The survey should take approximately 15 minutes to complete. Participation in this study is voluntary and responses will be anonymous. CLSI will collect and analyze the data and share with CDC.


Please contact Mr. David Sterry ([email protected]) if you have any questions about the survey or who should complete the survey. Upon completing the survey, all respondents will be provided with a link that will permit the download of a single electronic copy of a CLSI guideline related to fingerstick glucose testing (a $130 value). CDC collaboration in this study is not an endorsement by the Department of Health and Human Services (HHS) or CDC of any particular product, service, or enterprise.


Thank you for your help with this important study.


R egards,

 

David E. Sterry, MT (ASCP)

Director, Standards

Secretary, ISO/TC 212

Clinical and Laboratory Standards Institute

950 West Valley Road, Suite 2500

Wayne, PA  19087 USA www.clsi.org

Direct Line: 484.588.5942

Shape3

The mark ‘CDC’ is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise.

Fax: 610.688.0700

Email: [email protected]







5


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorLisa Kalman
File Modified0000-00-00
File Created2021-01-24

© 2024 OMB.report | Privacy Policy